NCT05297266

Brief Summary

Investigators will test if changes in CO2 is detected postoperatively in ischemic tissue in a replanted extremity of a traumatically amputated upper or lower extremity. IscAlert is measuring continuously CO2 in muscular and subcutaneous tissue. IscAlert is inserted distal to the operative field into normal muscle and/or subcutaneous tissue in the replanted extremity. Local tissue CO2 and temperature will be monitored continuously postoperatively for the next 10 days. If a reduced or totally obstructed blood flow appear (thrombosis), an increase in tissue CO2 and a lower local temperature will emerge rapidly as a sign of ischemia. This will be detected by the sensor which will alarm the investigators. This will lead to assessment of the replanted extremity and if restricted blood flow is diagnosed, a reoperation will be performed. After reoperation new sensors will be implanted for another ten days if applicable. Sixty patients will be enrolled to undergo the procedures. The IscAlert will be removed from the patient before the patient is discharged from the hospital or a maximum of 10 days (the event that occurs first). 500 devices is planned to be used in this clinical study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
17mo left

Started Nov 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Nov 2022Sep 2027

First Submitted

Initial submission to the registry

March 17, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

March 28, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

November 15, 2022

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Expected
Last Updated

April 28, 2026

Status Verified

April 1, 2026

Enrollment Period

2.6 years

First QC Date

March 17, 2022

Last Update Submit

April 27, 2026

Conditions

Keywords

IschemiaBiosensorReplantationCarbon dioxideTraumatic amputationOrthopedic surgeryLimb

Outcome Measures

Primary Outcomes (1)

  • Tissue CO2-level

    Tissue CO2-level (kPa) during insertion period

    10 days

Secondary Outcomes (5)

  • Bleeding

    10 days

  • Infection

    30 days

  • Length of stay at hospital

    30 days

  • Time to reduced blood flow in replanted extremity

    10 days

  • Number of re-operations

    30 days

Other Outcomes (8)

  • Number of pack-years

    30 days

  • Preoperative ischemia time

    12 hours

  • Intravenous fluid

    12 hours

  • +5 more other outcomes

Study Arms (1)

Patients with replanted extremity monitored by tissue CO2

EXPERIMENTAL

Patients with traumatic amputation of a limb who are undergoing replantation surgery and are monitored postoperatively with IscAlert biosensor measuring local tissue CO2 and temperature in the replanted extremity

Device: IscAlert

Interventions

IscAlertDEVICE

Insertion of a CO2- and temperature sensor in the distal part of the replanted extremity

Patients with replanted extremity monitored by tissue CO2

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be in need of extremity replantation surgery
  • Subject must be ≥ 18 years
  • Able to give written signed informed consent

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oslo University Hospital

Oslo, 0424, Norway

Location

MeSH Terms

Conditions

IschemiaAmputation, Traumatic

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsWounds and Injuries

Study Officials

  • Magne Røkkum, MD, Ph.D

    Oslo University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Prospective, interventional. Sixty patients (80 injured extremities) will receive tissue CO2 monitoring in the replanted extremity after traumatic amputation replant surgery.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 17, 2022

First Posted

March 28, 2022

Study Start

November 15, 2022

Primary Completion

June 30, 2025

Study Completion (Estimated)

September 30, 2027

Last Updated

April 28, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

No plan to share IPD to other researchers

Locations